Effect of PCSK9 inhibitors on remnant cholesterol and lipid residual risk: The LIPID-REAL registry.

Alberto Cordero, Mª Rosa Fernández Olmo,Gustavo A Cortez Quiroga,Cesar Romero-Menor,Lorenzo Fácila,José Seijas-Amigo,Juan Rondán Murillo,Miriam Sandin,Moisés Rodríguez-Mañero,María C Bello Mora,Alfonso Valle,Aisa Fornovi,Roman Freixa Pamias,Jordi Bañeras,Pedro Blanch García, María Milagros Clemente Lorenzo, Sergio Sánchez-Álvarez,Luis López-Rodríguez,José R González-Juanatey

European journal of clinical investigation（2022）

引用 5|浏览5

暂无评分

摘要

This multicenter and retrospective registry of real-world patients treated with PCSK9 inhibitors demonstrates a positive effect on cholesterol remnants and lipid residual risk beyond LDLc reductions.

查看译文

关键词

PCSK9 inhibitors,remnants,residual risk,triglycerides

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要